Karine Lheritier - novartis | 人才画像

基本信息

浏览量：60

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 114 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacité Du Remibrutinib Chez Les Patients Atteints D’urticaire Chronique Spontanée Avec Ou Sans Exposition Préalable Aux Biothérapies Dans Les Études De Phase 3 REMIX-1 Et REMIX-2

F. Bérard,G. Mosnaim,A.M. Giménez-Arnau,M. Hide,M. Lebwohl, M. Maurer,M. Metz, S.S. Saini,G. Sussman,S. Haemmerle,K. Lheritier,E.D. Martzloff, N. Seko, P. Wang, S. Gogate

Annales de Dermatologie et de Vénéréologie - FMCno. 8 (2024): A372-A373

引用0浏览0引用

Tolérance Du Remibrutinib Chez Les Patients Atteints D’urticaire Chronique Spontanée : Résultats Des Études De Phase 3 REMIX-1 Et REMIX-2

F. Bérard,P. Staubach, S.S. Saini,A.M. Giménez-Arnau,M. Hide,M. Lebwohl,G. Sussman,S. Haemmerle,K. Lheritier,E.D. Martzloff,A. Zharkov, M. Maurer

Annales de Dermatologie et de Vénéréologie - FMCno. 8 (2024): A364-A365

引用0浏览0引用

Remibrutinib Treatment Did Not Impact Total Serum Immunoglobulin Levels or Infection Rates in Patients with Chronic Spontaneous Urticaria: Phase 2b Study Results

Warner Carr, Ana Gimanez-Armau,Karine Lheritler,Sibylle Haemmerle,Artem Zharkov,Swapnil Dahale,Koremasa Hayama,Robert Snyder

Journal of Allergy and Clinical Immunologyno. 2 (2024): AB8-AB8

引用0浏览0引用

53683 Remibrutinib Provides Sustained Improvement in Itch Severity in Patients with Chronic Spontaneous Urticaria: Phase 2b Open-Label Extension Study

Robert Snyder,Alexander Greiner,Vipul Jain,Ana Maria Giménez-Arnau,Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Sibylle Haemmerle,Lee Clore

Journal of the American Academy of Dermatologyno. 3 (2024): AB80

引用0浏览0引用

Remibrutinib Monotherapy Reduced Rescue Medication in Chronic Spontaneous Urticaria Patients: Findings from a Phase 2b Extension Study

Lee Clore,Warner Carr,Jeffrey Tillinghast,Vipul Jain, John Reed,Petra Staubach,Karine Lheritier,Pauline Walsh,Ivan Nikolaev,Sibylle Haemmerle,Ana Maria Gimenez-Arnau

Journal of Allergy and Clinical Immunology（2024）

引用0浏览0引用

Efficacité Et Sécurité À Long Terme Du Remibrutinib Chez Les Patients Atteints D’urticaire Chronique Spontanée Dans Les Études De Phase 3 REMIX-1 Et REMIX-2

M. Metz,A.M. Giménez-Arnau,M. Hide,V. Jain,A. Khemis,M. Lebwohl, M. Palumbo, S.S. Saini,E. Savk,G. Sussman, R. Szalewski, I. Walecka Herniczek,H. Windom,S. Haemmerle,K. Lheritier, P.G.P. Machado,E.D. Martzloff, N. Seko, P. Wang,A. Zharkov

Annales de Dermatologie et de Vénéréologie - FMCno. 8 (2024): A347-A348

引用0浏览0引用

Time to Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients with Chronic Spontaneous Urticaria: Subgroup Analysis by Baseline Immunoglobulin-E Levels and Chronic Urticaria Index Status from a Phase 2b Extension Study

Alexander Greiner,Vipul Jain,Ana Gimenez-Arnau,Jeffrey Tillinghast,Karine Lheritier,Sibylle Haemmerle,Pauline Walsh,Ivan Nikolaev,Robert Snyder

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB266-AB266

引用0浏览0引用

Remibrutinib Treatment Has No Impact on Blood Counts in Patients with Chronic Spontaneous Urticaria: Results from Phase 2b 52-Week Extension Study Results

Alexander Greiner,Vipul Jain, Ana Gimanez-Armau,Jeffrey Tillinghast,Karine Lheritier,Pauline Walsh,Sibylle Haemmerle,Artem Zharkov,Robert Snyder

Journal of Allergy and Clinical Immunology（2024）

引用0浏览0引用

52859 Time to First Relapse During Treatment-Free Follow-Up Without Remibrutinib in Patients with Chronic Spontaneous Urticaria (CSU): Subgroup Analysis by Baseline Disease Status and CSU Duration from a Phase 2b Extension Study

Alexander Greiner,Vipul Jain,Ana Maria Giménez-Arnau,Jeffrey Tillinghast,Karine Lheritier,Sibylle Haemmerle,Pauline Walsh,Ivan Nikolaev,Robert Snyder

Journal of the American Academy of Dermatologyno. 3 (2024): AB340

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn